Involvement of serum retinoids and Leiden mutation in patients with esophageal, gastric, liver, pancreatic, and colorectal cancers in Hungary

doi:10.3748/wjg.v11.i48.7646

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 48

This Article

(0)

(5403)

(27)

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Clinical Research

World J Gastroenterol. Dec 28, 2005; 11(48): 7646-7650
Published online Dec 28, 2005. doi: 10.3748/wjg.v11.i48.7646

Full Size Figure Download Figure

Figure 1 Prevalence of Leiden mutation in patients with different gastrointestinal tumors. The number in abscissa indicates the number of patients (600 healthy blood donors used as control).

Citation: Mózsik G, Rumi G, Dömötör A, Figler M, Gasztonyi B, Papp E, Pár A, Pár G, Belágyi J, Matus Z, Melegh B. Involvement of serum retinoids and Leiden mutation in patients with esophageal, gastric, liver, pancreatic, and colorectal cancers in Hungary. World J Gastroenterol 2005; 11(48): 7646-7650
URL: https://www.wjgnet.com/1007-9327/full/v11/i48/7646.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i48.7646

Mózsik G, Rumi G, Dömötör A, Figler M, Gasztonyi B, Papp E, Pár A, Pár G, Belágyi J, Matus Z, Melegh B. Involvement of serum retinoids and Leiden mutation in patients with esophageal, gastric, liver, pancreatic, and colorectal cancers in Hungary. World J Gastroenterol 2005; 11(48): 7646-7650 [PMID: 16437692 DOI: 10.3748/wjg.v11.i48.7646]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.